… 6/9 Public Health /; Government Experience 2… years of expertise in global pharmaceutical and medical technology industries as an executive … including Orexo AB,Cascadian Therapeutics,AMAG Pharmaceuticals, Trillium Therapeutics,Sensorion SA, Harpoon …

… companies in the global medical device and life sciences … chief business officer, at Candela Medical. There, he led a … when was a subsidiary of AMAG Pharmaceuticals. “Imperative Care is deeply … and advising life science and healthcare businesses as a private …

… has worked in the global pharmaceutical and medical technology industries for nearly … AMAG Pharmaceuticals, where he led its turnaround and strategic sale to Covis Pharma … capabilities across cancer biology and medicinal chemistry to advance its research …

… in the biotechnology and pharmaceuticals space, including Flexion … by Otsuka Pharmaceutical Co), Mascoma, AMAG Pharmaceuticals, and Idenix Pharmaceuticals. Within … Spring Bank Pharmaceuticals, Proteostasis Therapeutics, Aegerion Pharmaceuticals, and ImpactRx …

… organizational transformation at global medical device and life sciences … as a subsidiary of AMAG Pharmaceuticals. “Imperative Care has … advising life science and healthcare businesses as a … is a commercial-stage medical technology company researching, …

… which was acquired by Otsuka Pharmaceutical Co.  He also previously served … Officer at Mascoma, AMAG Pharmaceuticals and Idenix Pharmaceuticals and held additional leadership … breakthrough therapy designation and orphan drug designation for Stargardt disease …

… record of successful drug approvals across … Pharmacovigilance, Quality, and Patient Advocacy at Ra Pharmaceuticals … companies, including Sucampo Pharmaceuticals, AMAG Pharmaceuticals, MedImmune (Biologics … . About Disc Medicine Disc Medicine (NASDAQ:IRON) …

KalVista Pharmaceuticals, Inc. (KALV) announced Tuesday that … President, CFO and Treasurer at AMAG Pharmaceuticals. He held leadership roles in … at Cubist Pharmaceuticals and began his career as a healthcare investment banker …

… legal back-and-forth, AMAG Pharmaceuticals has lost its bid to … Insurance Company (AGLIC), denying AMAG’s claims of business losses … preterm birth drug Makena. As a result, AMAG will not … AMAG owned the marketing rights to the controversial preterm birth drug …

… judge in Massachusetts denied a pharmaceutical manufacturer’s request for business … subsequent contamination to AMAG Pharmaceuticals’ production of a Pfizer drug didn’t constitute … policy. The case is captioned AMAG Pharmaceuticals v. American Guarantee and …